Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.57K Sell
185
-100
-35% -$836 ﹤0.01% 635
2023
Q4
$2.35K Buy
285
+100
+54% +$824 ﹤0.01% 657
2023
Q3
$1.54K Hold
185
﹤0.01% 679
2023
Q2
$1.55K Sell
185
-274
-60% -$2.34K ﹤0.01% 670
2023
Q1
$3.74K Hold
459
﹤0.01% 697
2022
Q4
$4K Buy
+459
New +$3.12K ﹤0.01% 721

Other funds holding HLN

Cambridge Trust's HLN Position: Q1 2024 in Review

Cambridge Trust reduced its Haleon (HLN) stake by 35% in Q1 2024, selling an estimated $836 and leaving 185 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Cambridge Trust first reported a position in HLN in Q4 2022 and has held it in 6 quarters since. The position peaked at $4K in Q4 2022. 599 funds tracked by Wall St. Rank hold HLN as of Q1 2024.

  • Cambridge Trust held 185 shares of Haleon worth $1.57K as of Q1 2024.
  • Cambridge Trust sold 100 Haleon shares in Q1 2024, an estimated $836.
  • Haleon made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #635 holding.
  • Cambridge Trust first reported a position in Haleon in Q4 2022 and has held it in 6 quarters since.
  • Cambridge Trust's Haleon position peaked at $4K in Q4 2022.
  • 599 funds tracked by Wall St. Rank held Haleon as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.